Mixed Salts Of A Single Entity Amphetamine Product Capsule, Extended Release
Product Images NDC 0406-8955

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mixed Salts Of A Single Entity Amphetamine Product (NDC 0406-8955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mixed Salt Chart (Mixed Salts Of A Single Entity Amphetamine Product 1)

This document shows the mean plasma concentrations of Dextro and Levoamphetamine at different time intervals. The concentrations are measured in ng/mL. The document also mentions the details of the amphetamine product extended-release capsules and amphetamine product tablets. The time intervals are given in hours.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

This appears to be a medication label for extended-release capsules of Dextroamphetamine and Amphetamine for the treatment of attention deficit hyperactivity disorder (ADHD). The capsules come in a bottle of 100 and are manufactured by Mallinckrodt Pharmaceuticals. However, the label is incomplete and contains some errors, making it difficult to provide accurate information.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

This is a medication description for NDC 0406-8953-01 which comes in the form of 100 capsules. The medication contains a combination of Dextroamphetamine sulfate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. These ingredients are present in extended-release capsules and the medication is a Mallinckrodt product. No dosage instructions are given.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

This text describes a medication with NDC 0206-8954-01 number and the form of this medication is 100 capsules. The name of this medication is "Extended-Release Capsules". The other information of this medication includes its composition which consists of Dextroamphetarine Saccharate, Amphetanine Aspartate Monohydrate, Dextroamphetamine Sufate, and Amphetamine Sulfate. The text also mentions a pharmaceutical company named "Mallinckrodt". The remaining texts are either symbols or unreadable characters.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

This is a prescription medication with the National Drug Code 0406-5955-01, available in a bottle containing 100 capsules. The capsule contains a combination of dextroamphetamine and amphetamine salts in four different forms- dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate as an extended-release version. This medication is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is recommended to provide the medication guide separately for each patient. The manufacturer of this medication is Mallinckrodt.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

This is a medication label for extended-release capsules containing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. The medication comes in a bottle of 100 capsules and has a National Drug Code (NDC) number of 0406-8956-01. The label includes instructions for pharmacists to dispense the medication guide provided separately for each patient. There are also instructions for storage and dosage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.